NCT06469541

Brief Summary

The purpose of our investigation is to retrospectively assess visual outcomes, refractive stability, safety features of the lens and the incidence of developing PCO (posterior capsular opacification) in a 12-month period following mono- or bilateral implantation of the hydrophobic acrylic monofocal IOL, Bi-Flex 877PAY (Medicontur).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 11, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 31, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
7 months until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
Last Updated

June 21, 2024

Status Verified

April 1, 2023

Enrollment Period

4 months

First QC Date

May 31, 2023

Last Update Submit

June 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Primary objective

    To evaluate the monocular Uncorrected Distance Visual Acuity (UCDVA) 1 year after IOL implantation

    12 months after IOL implantation

Secondary Outcomes (1)

  • Secondary onjective

    12 months after IOL implantation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The enrolled subjects will be the patients who underwent cataract surgery in one or both eyes and who were implanted with Bi-Flex 877PAY IOL mono- or bilaterally. For evaluation of records consecutive implanted patients with regular post-operative visits over a 12 months period will be included.

You may qualify if:

  • Male or female patients who underwent cataract surgery in one or both eyes and who were implanted with Bi-Flex 877PAY IOL mono- or bilaterally.
  • Patients with regular post-operative visits over 12 months period after surgery.
  • Patients of any age above 18 years and any medical history who are eligible according the investigator's decision.

You may not qualify if:

  • preoperative corneal astigmatism \> 1.5 D
  • uncontrolled diabetic retinopathy
  • iris neovascularisation
  • serious intraoperative complications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NHS Ayrshire and Arran

Ayr, Scotland, KA7 2SP, United Kingdom

Location

MeSH Terms

Conditions

Cataract

Condition Hierarchy (Ancestors)

Lens DiseasesEye Diseases

Study Officials

  • Sathish Srinivasan, Prof.

    NHS Ayrshire and Arran

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2023

First Posted

June 21, 2024

Study Start

April 11, 2023

Primary Completion

July 31, 2023

Study Completion

December 1, 2023

Last Updated

June 21, 2024

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations